載入...
Acute Respiratory Distress Syndrome and Posterior Reversible Encephalopathy Syndrome following Rituximab Therapy
The anti-CD20 monoclonal antibody rituximab is associated with rare but significant adverse events, notably posterior reversible encephalopathy syndrome (PRES) and acute respiratory distress syndrome (ARDS). We report a case of concomitant ARDS and PRES developing after rituximab therapy for treatme...
Na minha lista:
| 發表在: | Case Rep Nephrol Dial |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
S. Karger AG
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4886031/ https://ncbi.nlm.nih.gov/pubmed/27275457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000444250 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|